Patent ID: 8618165
Filing Date: 2013-12-31
Classification: A61P,C07C,C07D,C11C

Abstract:
1. A method for the treatment of a disease or condition chosen from peripheral insulin resistance; a diabetic condition; obesity or an overweight condition; and/or an inflammatory disease or condition; comprising administering to a human or animal patient in need thereof a pharmaceutically effective amount of a compound of formula (I) wherein R X represents a carboxylic acid group or a carboxylate group, or any pharmaceutically acceptable salt thereof; with the provisos that: the compound of formula (I) is not (all-Z)-4,7,10,13,16,19-docosahexaenoic acid (DHA), alpha-methyl DHA, alpha-methyl DHA methyl ester, alpha-methyl DHA ethyl ester, or alpha-hydroxy DHA ethyl ester, and R